X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1969) 1969
Publication (281) 281
Newsletter (111) 111
Book Chapter (23) 23
Newspaper Article (23) 23
Book Review (17) 17
Conference Proceeding (3) 3
Magazine Article (3) 3
Dissertation (2) 2
Web Resource (2) 2
Book / eBook (1) 1
Trade Publication Article (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
posaconazole (1987) 1987
index medicus (1105) 1105
humans (1003) 1003
voriconazole (721) 721
itraconazole (519) 519
microbiology (515) 515
antifungal agents - therapeutic use (514) 514
male (496) 496
infectious diseases (475) 475
pharmacology & pharmacy (460) 460
fluconazole (429) 429
female (418) 418
antifungal agents (389) 389
middle aged (353) 353
amphotericin-b (337) 337
antifungal agents - pharmacology (325) 325
adult (323) 323
triazoles - therapeutic use (313) 313
mycoses (295) 295
amphotericin b (291) 291
mycology (283) 283
mucormycosis (279) 279
aspergillosis (260) 260
pharmacokinetics (254) 254
prophylaxis (240) 240
health aspects (236) 236
antifungal agents - administration & dosage (234) 234
aged (216) 216
triazoles - administration & dosage (211) 211
animals (210) 210
infections (210) 210
triazoles - pharmacology (204) 204
microbial sensitivity tests (198) 198
caspofungin (193) 193
treatment outcome (193) 193
research (192) 192
zygomycosis (190) 190
therapy (189) 189
epidemiology (188) 188
care and treatment (183) 183
infection (180) 180
mycoses - drug therapy (174) 174
triazoles (173) 173
transplantation (171) 171
invasive fungal-infections (169) 169
analysis (163) 163
fungal-infections (158) 158
chemotherapy (155) 155
fungi (149) 149
diagnosis (148) 148
adolescent (147) 147
antifungal agents - pharmacokinetics (141) 141
fungal infections (138) 138
young adult (135) 135
immunology (132) 132
mycoses - prevention & control (131) 131
risk factors (131) 131
triazoles - pharmacokinetics (129) 129
drug therapy (126) 126
patients (126) 126
retrospective studies (126) 126
susceptibility (126) 126
invasive aspergillosis (124) 124
safety (124) 124
neutropenia (122) 122
dermatology (120) 120
aspergillus (119) 119
mice (119) 119
drug resistance, fungal (118) 118
leukemia (117) 117
cancer (115) 115
immunocompromised host (115) 115
mortality (115) 115
antifungal agents - adverse effects (114) 114
hematology (111) 111
in-vitro (108) 108
child (107) 107
drugs (105) 105
internal medicine (105) 105
antifungal prophylaxis (102) 102
disease (101) 101
dosage and administration (101) 101
micafungin (100) 100
mycoses - microbiology (100) 100
aspergillosis - drug therapy (99) 99
medical research (99) 99
triazoles - adverse effects (99) 99
amphotericin b - therapeutic use (98) 98
resistance (98) 98
drug interactions (97) 97
in-vitro activities (97) 97
salvage therapy (97) 97
therapeutic drug monitoring (97) 97
antiparasitic agents (93) 93
medicine & public health (92) 92
oncology (91) 91
azoles (89) 89
benznidazole (89) 89
liposomal amphotericin-b (87) 87
management (87) 87
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1992) 1992
French (41) 41
Spanish (39) 39
German (37) 37
Polish (5) 5
Russian (5) 5
Turkish (5) 5
Korean (3) 3
Czech (2) 2
Chinese (1) 1
Hungarian (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S32
Le posaconazole est un antifongique triazole utilise majoritairement dans le cadre des prophylaxies fongiques. Il se decline sous trois formes galeniques : la... 
Posaconazole
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 02/2004, Volume 38, Issue 3, pp. e15 - e20
A 41-year-old woman with no known immunosuppression experienced a 12-year period of a relapsing phaeohyphomycosis. Despite administration of multiple courses... 
posaconazole
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S260 - S261
Similar to other triazoles, isavuconazole (ISAV) is an inhibitor of many CYP3A4 metabolized drugs including tacrolimus. TAC requires significant dose reduction... 
Tacrolimus | Posaconazole | Triazoles | Cytochrome P-450
Journal Article
Medecine et Maladies Infectieuses, ISSN 0399-077X, 06/2019, Volume 49, Issue 4, p. S24
Materiels et methodes Ce travail met en exergue la grande diversite d'especes fongiques responsables d'infections sous-cutanees chez les patients TR. La... 
Tacrolimus | Mycoses | Azathioprine | Posaconazole
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 04/2014, Volume 136, Issue 15, p. 5627
Journal Article
Antimicrobial Agents & Chemotherapy, ISSN 0066-4804, 05/2001, Volume 45, Issue 5, pp. 1355 - 1359
A checkerboard methodology, based on standardized methods proposed by the National Committee for Clinical Laboratory Standards for broth microdilution... 
posaconazole
Journal Article
Pharmacotherapy, ISSN 0277-0008, 06/2007, Volume 27, Issue 6, pp. 825 - 834
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 08/2001, Volume 18, Issue 2, pp. 167 - 172
The antifungal activity of posaconazole (SCH56592), a new triazole antifungal, against stock cultures and fresh clinical isolates of a wide range of pathogenic... 
posaconazole
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 12/2011, Volume 17, Issue 12, pp. 1859 - 1867
Zygomycosis is an important emerging fungal infection, associated with high morbidity and mortality. The Working Group on Zygomycosis of the European... 
treatment | zygomycosis | Epidemiology | mucormycosis | Europe | Mucormycosis | Treatment | Zygomycosis | VORICONAZOLE | INFECTIOUS DISEASES | MICROBIOLOGY | INVASIVE FUNGAL-INFECTIONS | AMPHOTERICIN-B | IN-VITRO SUSCEPTIBILITIES | CELL TRANSPLANT RECIPIENTS | POSACONAZOLE PROPHYLAXIS | SURVEILLANCE NETWORK TRANSNET | BREAKTHROUGH ZYGOMYCOSIS | HEMATOLOGIC MALIGNANCIES | Age Distribution | Diabetes Complications | Prospective Studies | Fungi - classification | Humans | Middle Aged | Zygomycosis - mortality | Child, Preschool | Fungi - isolation & purification | Infant | Male | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Aged, 80 and over | Adult | Female | Hematologic Neoplasms - complications | Child | Risk Factors | Wounds and Injuries - complications | Europe - epidemiology | Zygomycosis - epidemiology | Adolescent | Survival Analysis | Sex Distribution | Aged | Antifungal Agents - administration & dosage | Amphotericin B | Analysis | Antiparasitic agents | Transplantation | Diabetes | Health aspects | Hematopoietic stem cells | Multivariate analysis | Medical research | Mortality | Cell culture | Diabetes mellitus | stem cell transplantation | Case reports | Malignancy | Regression analysis | Survival | Trauma | Morbidity | Soft tissues | Infection | Databases | Surgery | Caspofungin | Posaconazole | Age
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 12/2019, Volume 183, p. 111660
This mini-review focuses on leishmanicidal drugs that were sourced from small molecules previously approved for other diseases. The mechanisms of action of... 
Miltefosine | Leishmanicidal drugs | Amphotericin B | Fluconazole | Posaconazole | Itraconazole
Journal Article
Mycoses, ISSN 0933-7407, 01/2011, Volume 54, pp. 12 - 16
Journal Article
Mycoses, ISSN 0933-7407, 01/2011, Volume 54, pp. 7 - 11
Journal Article
Archivos Argentinos de Pediatria, ISSN 0325-0075, 06/2018, Volume 116, Issue 3, pp. e451 - e454
Journal Article
Dermatology Online Journal, ISSN 1087-2108, 2017, Volume 23, Issue 7
Sporotrichosis is a subcutaneous mycotic infection caused by Sporothrix schenckii, a group of common saprophytes of soil, plants, and organic debris.... 
Posaconazole | Sporothrix schenckii | Disseminated sporotrichosis
Journal Article
Journal Article
Journal of Infection in Developing Countries, ISSN 2036-6590, 10/2016, Volume 10, Issue 10, pp. 1156 - 1158
We present a case report of a fungal bloodstream infection due to an unusual pathogen. This is a 30 years-old female patient diagnosed with Crohn’s disease and... 
Immunosuppression | Candidemia | Posaconazole | Candida ciferrii
Journal Article
International Journal of Infectious Diseases, ISSN 1201-9712, 06/2019, Volume 83, pp. 130 - 138
Novel formulations (gastro-resistant tablet and intravenous solution) of posaconazole (POS) have been approved in prophylaxis and therapy of invasive fungal... 
High-risk patient | Invasive fungal infection | Clinical effectiveness | Posaconazole serum level | Neutropenia | Medical research | Care and treatment | Hospitals | Analysis | Mortality | Mycoses | Medicine, Experimental | Posaconazole
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.